| DY2 Stock | | | EUR 18.16 0.29 1.57% |
Director
Mr. Arthur D. Kowaloff is Director of the Company. he serves as director since 2016. Mr. Kowaloff has served as a director of United States Enrichment Corporationration a wholly owned subsidiary of Centrus Energy. In 2014 and 2015, Mr. Kowaloff served as a director of Reichhold Chemicals, Inc. and from 2010 until 2012, he served as lead director of Metropolitan Health Networks, Inc. From 1998 to 2003, Mr. Kowaloff served as a Managing Director of BNY Capital Markets, Inc. From 1991 to 1998, he was Chief Operating Officer and Senior Managing Director of Patricof Company Capital Corporationrationration. Prior to that, Mr. Kowaloff was an attorney at the New York City firm of Willkie Farr Gallagher, where he served as Senior Partner and Executive Committee Member and specialized in corporate and securities law and mergers and acquisitions. Mr. Kowaloff is currently a Trustee of Carleton College, the President and a Director of the PBP Foundation of New York, and a Director and Chairman of the Audit and Compliance and Compensation Committees of the Greater Hudson Valley Health System. since 2016.
| Age | 72 |
| Tenure | 8 years |
| Phone | 844-848-0137 |
| Web | https://www.dentsplysirona.com |
Kowaloff received a B.A. from Carleton College and holds a Juris Doctor degree from Yale Law S
Dentsply Sirona Management Efficiency
The company has return on total asset
(ROA) of
0.0345 % which means that it generated a profit of $0.0345 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.2157) %, meaning that it generated substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities.
Dentsply Sirona has accumulated 1.83
B in total debt with debt to equity ratio
(D/E) of 0.48, which is about average as compared to similar companies. Dentsply Sirona has a current ratio of 1.37, which is within standard range for the sector. Debt can assist Dentsply Sirona until it has trouble settling it off, either with new capital or with free cash flow. So, Dentsply Sirona's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dentsply Sirona sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dentsply to invest in growth at high rates of return. When we think about Dentsply Sirona's use of debt, we should always consider it together with cash and equity.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina. DENTSPLY SIRONA operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15000 people. Dentsply Sirona (DY2) is traded on Frankfurt Exchange in Germany and employs 51 people.
Management Performance
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Wagner, Chief Officer | |
| Janet Vergis, Independent Director | |
| Cheree Johnson, Chief VP | |
| Lisa Yankie, Senior Vice President Chief Human Resources Officer and Communications | |
| Francis Lunger, Independent Director | |
| Jorge Gomez, Chief Financial Officer, Executive Vice President | |
| Chidam Chidambaram, Senior Vice President Chief Digital Officer | |
| Andrew Robinson, VP Officer | |
| Ranjit Chadha, Chief Accounting Officer, Principal Accounting Officer | |
| Andrea Daley, VP Relations | |
| Harry Kraemer, Independent Director | |
| Betsy Holden, Independent Director | |
| Leslie Varon, Independent Director | |
| Eric Brandt, Non-Executive Independent Chairman of the Board | |
| Gregory Lucier, Independent Director | |
| Donald Casey, Chief Executive Officer, Director | |
| William Newell, Senior Vice President Chief Segment Officer | |
| Andreas Frank, Ex Group | |
| Willie Deese, Independent Director | |
| Daniel Key, Senior Vice President Chief Supply Chain Officer | |
| Simon Campion, Pres CEO | |
| Erania Brackett, VP Officer | |
| Walter Petersohn, Senior Vice President Chief Commercial Officer | |
| Matthew Coggin, Senior Vice President Business Development and Strategy Officer | |
| Keith Ebling, Executive Vice President General Counsel, Secretary | |
| Michael Alfano, Independent Director | |
| Clyde Hosein, Director | |
| Cord Staehler, Senior Vice President, Chief Technology Officer | |
| Arthur Kowaloff, Independent Director | |
| Glenn Coleman, Ex CFO | |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Dentsply Stock
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock: Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more detail on how to invest in Dentsply Stock please use our
How to Invest in Dentsply Sirona guide.
You can also try the
Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.